# Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)

> **NCT00857506** · PHASE2 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 152 (actual)

## Conditions studied

- Alzheimer's Disease
- Mild Cognitive Impairment

## Interventions

- **DRUG:** florbetapir F 18

## Key facts

- **NCT ID:** NCT00857506
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2013-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00857506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00857506, "Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00857506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*